Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more
Market Cap & Net Worth: Brain+ ApS (BRAINP)
Brain+ ApS (CO:BRAINP) has a market capitalization of $1.22 Million (Dkr8.84 Million) as of March 18, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #48188 globally and #370 in its home market, demonstrating a 178.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brain+ ApS's stock price Dkr0.01 by its total outstanding shares 1132939014 (1.13 Billion).
Brain+ ApS Market Cap History: 2021 to 2026
Brain+ ApS's market capitalization history from 2021 to 2026. Data shows change from $533.28 Million to $1.22 Million (-75.96% CAGR).
Brain+ ApS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brain+ ApS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.86x
Brain+ ApS's market cap is 1.86 times its annual revenue
1.54x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $533.28 Million | $3.99 Million | -$7.08 Million | 133.58x | N/A |
| 2022 | $266.64 Million | $2.64 Million | -$9.68 Million | 100.88x | N/A |
| 2023 | $30.25 Million | $2.35 Million | -$19.12 Million | 12.86x | N/A |
| 2024 | $14.63 Million | $7.86 Million | -$12.05 Million | 1.86x | N/A |
Competitor Companies of BRAINP by Market Capitalization
Companies near Brain+ ApS in the global market cap rankings as of March 18, 2026.
Key companies related to Brain+ ApS by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Brain+ ApS Historical Marketcap From 2021 to 2026
Between 2021 and today, Brain+ ApS's market cap moved from $533.28 Million to $ 1.22 Million, with a yearly change of -75.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr1.22 Million | -22.00% |
| 2025 | Dkr1.56 Million | -89.34% |
| 2024 | Dkr14.63 Million | -51.65% |
| 2023 | Dkr30.25 Million | -88.65% |
| 2022 | Dkr266.64 Million | -50.00% |
| 2021 | Dkr533.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Brain+ ApS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.22 Million USD |
| MoneyControl | $1.22 Million USD |
| MarketWatch | $1.22 Million USD |
| marketcap.company | $1.22 Million USD |
| Reuters | $1.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.